德纳维制药(DVAX.OQ)今日盘中股价大涨5.07%,引起了市场广泛关注。公司最新公布的2024年第三季度财报显示,德纳维每股收益为12美分,高于分析师平均预期的11美分,这成为推动股价上涨的主要原因。
数据显示,德纳维公司第三季度营收同比增长16%,达到8063万美元,尽管略低于分析师预期的8417万美元。公司本季度净收入为1759万美元。除盈利超预期外,分析师们普遍看好德纳维的长期发展前景,目前对该公司的平均评级为"买入"。
德纳维公司今年迄今的股价表现较为平淡,目前下跌12.1%。但在业绩超预期的利好消息刺激下,该股今日反弹走高,体现了市场对公司当前经营状况的认可。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.